title: [Metabolic disorders under antipsychotic treatment].
abstract: Patients with severe mental illness, such as schizophrenia, depression or bipolar disorder, are more likely to be overweight and to suffer from dyslipidaemia, diabetes or cardiovascular disease. Unhealthy lifestyles, including poor diet and sedentary behaviour, but also pharmacotherapy contribute to the adverse risk profile. This article reviews the epidemiology and pharmacodynamics of metabolic abnormalities in psychiatric patients treated with antipsychotics, focusing on substance-specific differences.
authors.affiliation: Klinik und Poliklinik für Psychiatrie, Medizinische Fakultät der Universität Leipzig, Semmelweisstr. 10, 04103, Leipzig, Deutschland.
authors.forename: N
authors.initials: N
authors.lastname: Steffenhagen
authors.forename: C
authors.initials: C
authors.lastname: Rummel-Kluge
authors.forename: H
authors.initials: H
authors.lastname: Himmerich
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects*; D005858:Germany; D006801:Humans; D008659:Metabolic Diseases / Q000139:chemically induced* / Q000453:epidemiology*; D015995:Prevalence; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D014150:Antipsychotic Agents